Ads
related to: Renal Cell Carcinoma and Metastatic Renal Cell Carcinomaamazon.com has been visited by 1M+ users in the past month
Search results
Drug targeting clear cell renal cell carcinoma shows promising approach
Newswise· 4 days agoApril 23, 2024 – In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center,...
Allogene secures $15 million grant for cancer trial By Investing.com
Investing.com· 16 hours agoThe funding is earmarked to support the Phase 1 TRAVERSE trial, which is evaluating the safety and...
Immunotherapy After Kidney Cancer Surgery Improves Overall Survival
Technology Networks· 1 week agoTreatment with pembrolizumab, an immunotherapy drug, after surgery significantly prolonged overall...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks· 2 days agoFree Report) reported adjusted earnings of $2.07 per share for first-quarter 2024, beating the Zacks Consensus Estimate of $1.94. Earnings rose 48% year over year on a reported basis and 54% ...
Janux a new buy at Jones on lead assets for solid tumors
Seeking Alpha· 1 week agoJones Trading initiates Janux Therapeutics at buy, citing the promise behind the company's...
Mirae Asset Global Investments Co. Ltd. Trims Stock Position in Iovance Biotherapeutics, Inc....
ETF DAILY NEWS· 4 days agoMirae Asset Global Investments Co. Ltd. trimmed its stake in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 3.4% during the fourth quarter, according to its most recent 13F filing ...
Merck (MRK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 day agoOutside the U.S., KEYTRUDA growth was driven by continued uptake in earlier-stage cancers, including high-risk, early stage, triple-negative breast...
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Morningstar· 2 days agoThe NDA is supported by results from JUPITER...
Merck highlights progress on HIV, hypertension, cervical cancer drugs
WFMZ Eastern Pennsylvania and Western New Jersey· 1 day agoMerck got off to an excellent start in the first quarter of 2024. Wall Street met the news with...
Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
Zacks via Yahoo Finance· 2 weeks agoXTX202, on the other hand, is being developed in a phase II study to treat patients with metastatic ...
Ads
related to: Renal Cell Carcinoma and Metastatic Renal Cell Carcinoma
